Stock Events

Stock Events

Roche 

CHF318
0
+CHF0+0% Today

Statistics

Day High
318.4
Day Low
315.4
52W High
321.9
52W Low
291
Volume
138,608
Avg. Volume
984,189
Mkt Cap
0
P/E Ratio
19.84
Dividend Yield
3.08%
Dividend
9.8

Upcoming

12
MAR 27
Dividend Ex
Estimated
 
16
MAR 27
Dividend Payment
Estimated
 
13
MAR 28
Dividend Ex
Estimated
 
17
MAR 28
Dividend Payment
Estimated
 

Dividends

3.08%Dividend Yield
Mar 26
CHF9.8
Mar 25
CHF9.7
Mar 24
CHF9.6
Mar 23
CHF9.5
Mar 22
CHF9.3
10Y Growth
1.92%
5Y Growth
1.49%
3Y Growth
1.04%
1Y Growth
1.03%

Earnings

29JanExpected
Q4 2025
8.08
8.14
8.21
8.28
Expected EPS
8.277572299472
Actual EPS
8.07603308575

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ROP.SW. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap297.32B
Novartis competes directly with Roche in multiple areas including oncology, neuroscience, and immunology, making it a primary competitor.
Pfizer
PFE
Mkt Cap161.09B
Pfizer competes with Roche in the pharmaceutical sector, particularly in the development of cancer and immunology drugs.
Merck
MRK
Mkt Cap298.84B
Merck is a key competitor in the oncology space, directly competing with Roche's cancer drug portfolio.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson competes across a broad range of healthcare products, including pharmaceuticals that overlap with Roche's offerings.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie competes in the biopharmaceutical field, particularly in areas like immunology and oncology, overlapping with Roche's interests.
AMGEN
AMGN
Mkt Cap187.56B
Amgen competes with Roche in the biotech sector, especially in cancer and hematology.
Bristol-Myers Squibb
BMY
Mkt Cap121.69B
Bristol Myers Squibb competes in the pharmaceutical and biopharmaceutical sectors, particularly in cancer, which is a key area for Roche.
GSK
GSK
Mkt Cap113.29B
GlaxoSmithKline competes with Roche in several areas including pharmaceuticals and vaccines.
Sanofi
SNY
Mkt Cap116.63B
Sanofi competes with Roche in the pharmaceutical sector, including treatments for rare diseases, which Roche also focuses on.
Astrazeneca
AZN
Mkt Cap315.47B
AstraZeneca competes with Roche in the development of drugs for various diseases, including cancer, respiratory, and cardiovascular diseases.

About

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, and internationally. The company offers pharmaceutical products in the therapeutic areas of oncology, neuroscience, infectious diseases, immunology, hemophilia, ophthalmology, dermatology, respiratory, anemia, inflammatory and autoimmune, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, cardiovascular, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). Roche Holding AG was founded in 1896 and is headquartered in Basel, Switzerland.
Show more...
CEO
Dr. Severin Schwan Ph.D.
Employees
103249
Country
CH
ISIN
CH1499059983

Listings

MI
IT
1ROG.MI
MI
IT
1RO.MI
MX
MX
ROP1N.MX
XETRA
DE
RHO.XETRA

0 Comments

Share your thoughts

FAQ

What is Roche stock price today?▼
The current price of ROP.SW is CHF318 CHF — it has increased by +0% in the past 24 hours. Watch Roche stock price performance more closely on the chart.
What is Roche stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Roche stocks are traded under the ticker ROP.SW.
When is the next Roche earnings date?▼
Roche is going to release the next earnings report on July 23, 2026.
What were Roche earnings last quarter?▼
ROP.SW earnings for the last quarter are 8.08 CHF per share, whereas the estimation was 8.28 CHF resulting in a -2.43% surprise. The estimated earnings for the next quarter are N/A CHF per share.
Does Roche pay dividends?▼
Yes, ROP.SW dividends are paid annual. The last dividend per share was 9.8 CHF. As of today, Dividend Yield (FWD)% is 3.08%.
How many employees does Roche have?▼
As of April 07, 2026, the company has 103,249 employees.
In which sector is Roche located?▼
Roche operates in the Health Care sector.
When did Roche complete a stock split?▼
Roche has not had any recent stock splits.
Where is Roche headquartered?▼
Roche is headquartered in Basel, CH.